INDICATIONS:
-
Symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD)
-
Gastro-esophageal reflux disease Long-term Management (GERD maintenance)
-
Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
-
Active duodenal ulcer
-
Active benign gastric ulcer
-
Zollinger-Ellison syndrome
-
In combination with appropriate antibacterial therapeutic regimens for the eradication of H. pylori in patients with peptic ulcer disease
CONTRAINDICATIONS:
-
​Hypersensitivity to Rabeprazole or other proton pump inhibitors
-
Use in caution with children, as there is no experience of its use in this group
Rabeprazole Sodium
Korab 20
Proton Pump Inhibitor
CONTENTS:
Each tablet contains 20 mg of Rabeprazole Sodium​
DOSAGE:
Adults/Elderly
-
Erosive or Ulcerative GERD: 20 mg once daily for 4 to 8 weeks
-
GERD Maintenance: maintenance dose of Korab 20 mg once daily, depending on the patient response
-
Active Duodenal Ulcer and Active Benign Gastric Ulcer: 20 mg taken once daily in the morning
-
Zollinger-Ellison syndrome: recommended starting dose of 60 mg once daily, to be titrated upwards to 120 mg / day based on individual patient needs
-
Eradication of H. pylori infection: combination of 20 mg twice daily in the morning before breakfast + clarithromycin 500 mg twice daily and amoxicillin 1g twice daily
​
AVAILABILITY:
Box of 100's
